New approval for treatment of Small Cell Lung Cancer (SCLC)
FDA Approves Imdelltra (tarlatamab-dlle) for Extensive Stage Small Cell Lung Cancer
Written by colleague, Matthew Reiss, MSE, PhD, Manager, Precision Medicine...
FDA Approves Imdelltra (tarlatamab-dlle) for Extensive Stage Small Cell Lung Can...